Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective studyMichinori Hamaoka(Hiroshima University), Hideki Ohdan(Hiroshima University)PLoS ONEMay 29, 201910.1371/journal.pone.0217586Cited by 57SaveCiteExport RISWatch citationsRelated PapersGasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation|PLoS ONE|2016|193Establishment of a novel overlay culture method that enables immune response assessment using gastric cancer organoids|Heliyon|2023|11